Found: 12
Select item for more details and to access through your institution.
PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis.
- Published in:
- Nature Communications, 2013, v. 4, n. 3, p. 1618, doi. 10.1038/ncomms2604
- By:
- Publication type:
- Article
Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24010-1
- By:
- Publication type:
- Article
Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
- Published in:
- Journal of Pathology, 2012, v. 226, n. 4, p. 645, doi. 10.1002/path.3957
- By:
- Publication type:
- Article
Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01107-0
- By:
- Publication type:
- Article
Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025547
- By:
- Publication type:
- Article
Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005572
- By:
- Publication type:
- Article
Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2008, v. 3, n. 7, p. 1, doi. 10.1371/journal.pone.0002779
- By:
- Publication type:
- Article
APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase‐independent activity.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 5, p. 643, doi. 10.1002/mc.22956
- By:
- Publication type:
- Article
Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00731-0
- By:
- Publication type:
- Article
Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1–ERK1/2–p70S6K signalling pathway.
- Published in:
- Liver International, 2010, v. 30, n. 9, p. 1315, doi. 10.1111/j.1478-3231.2010.02307.x
- By:
- Publication type:
- Article
Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
- Published in:
- Liver International, 2010, v. 30, n. 1, p. 139, doi. 10.1111/j.1478-3231.2009.02133.x
- By:
- Publication type:
- Article